GO:0003674 | molecular_function | 46.43% (26/56) | 1.14 | 2e-05 | 0.000606 |
GO:0101005 | ubiquitinyl hydrolase activity | 5.36% (3/56) | 5.85 | 1.9e-05 | 0.000646 |
GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity | 5.36% (3/56) | 5.85 | 1.9e-05 | 0.000646 |
GO:0019783 | ubiquitin-like protein-specific protease activity | 5.36% (3/56) | 5.85 | 1.9e-05 | 0.000646 |
GO:0016579 | protein deubiquitination | 5.36% (3/56) | 6.05 | 1.2e-05 | 0.000975 |
GO:0070646 | protein modification by small protein removal | 5.36% (3/56) | 6.05 | 1.2e-05 | 0.000975 |
GO:0003676 | nucleic acid binding | 16.07% (9/56) | 2.59 | 1.6e-05 | 0.000981 |
GO:0070647 | protein modification by small protein conjugation or removal | 5.36% (3/56) | 5.46 | 4.3e-05 | 0.001139 |
GO:0003723 | RNA binding | 8.93% (5/56) | 4.1 | 1.1e-05 | 0.00265 |
GO:0009889 | regulation of biosynthetic process | 7.14% (4/56) | 3.54 | 0.000395 | 0.00393 |
GO:0031326 | regulation of cellular biosynthetic process | 7.14% (4/56) | 3.54 | 0.000395 | 0.00393 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 7.14% (4/56) | 3.54 | 0.000395 | 0.00393 |
GO:0010556 | regulation of macromolecule biosynthetic process | 7.14% (4/56) | 3.54 | 0.000395 | 0.00393 |
GO:0010468 | regulation of gene expression | 7.14% (4/56) | 3.54 | 0.000395 | 0.00393 |
GO:0008150 | biological_process | 32.14% (18/56) | 1.31 | 0.000167 | 0.003995 |
GO:0031323 | regulation of cellular metabolic process | 7.14% (4/56) | 3.45 | 0.00049 | 0.004042 |
GO:0060255 | regulation of macromolecule metabolic process | 7.14% (4/56) | 3.45 | 0.00049 | 0.004042 |
GO:0051171 | regulation of nitrogen compound metabolic process | 7.14% (4/56) | 3.49 | 0.000446 | 0.0041 |
GO:0080090 | regulation of primary metabolic process | 7.14% (4/56) | 3.49 | 0.000446 | 0.0041 |
GO:0043412 | macromolecule modification | 10.71% (6/56) | 2.59 | 0.000472 | 0.004179 |
GO:0019222 | regulation of metabolic process | 7.14% (4/56) | 3.41 | 0.00055 | 0.004384 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 7.14% (4/56) | 3.57 | 0.000366 | 0.004603 |
GO:0008234 | cysteine-type peptidase activity | 5.36% (3/56) | 4.44 | 0.000362 | 0.004804 |
GO:0044428 | nuclear part | 5.36% (3/56) | 4.46 | 0.000345 | 0.004844 |
GO:0006464 | cellular protein modification process | 10.71% (6/56) | 2.68 | 0.000333 | 0.004978 |
GO:0036211 | protein modification process | 10.71% (6/56) | 2.68 | 0.000333 | 0.004978 |
GO:0051252 | regulation of RNA metabolic process | 7.14% (4/56) | 3.61 | 0.00033 | 0.005635 |
GO:2001141 | regulation of RNA biosynthetic process | 7.14% (4/56) | 3.61 | 0.00033 | 0.005635 |
GO:0006355 | regulation of transcription, DNA-templated | 7.14% (4/56) | 3.61 | 0.00033 | 0.005635 |
GO:1903506 | regulation of nucleic acid-templated transcription | 7.14% (4/56) | 3.61 | 0.00033 | 0.005635 |
GO:0097159 | organic cyclic compound binding | 19.64% (11/56) | 1.6 | 0.00081 | 0.006046 |
GO:1901363 | heterocyclic compound binding | 19.64% (11/56) | 1.6 | 0.00081 | 0.006046 |
GO:0044267 | cellular protein metabolic process | 10.71% (6/56) | 2.42 | 0.000883 | 0.006392 |
GO:0044237 | cellular metabolic process | 17.86% (10/56) | 1.6 | 0.001425 | 0.010015 |
GO:0006376 | mRNA splice site selection | 1.79% (1/56) | 8.78 | 0.002267 | 0.014258 |
GO:0006359 | regulation of transcription by RNA polymerase III | 1.79% (1/56) | 8.78 | 0.002267 | 0.014258 |
GO:0016480 | negative regulation of transcription by RNA polymerase III | 1.79% (1/56) | 8.78 | 0.002267 | 0.014258 |
GO:0005685 | U1 snRNP | 1.79% (1/56) | 8.78 | 0.002267 | 0.014258 |
GO:0015672 | monovalent inorganic cation transport | 3.57% (2/56) | 4.62 | 0.003027 | 0.018084 |
GO:0044238 | primary metabolic process | 17.86% (10/56) | 1.46 | 0.002966 | 0.018179 |
GO:0140096 | catalytic activity, acting on a protein | 10.71% (6/56) | 2.01 | 0.003635 | 0.021187 |
GO:0120114 | Sm-like protein family complex | 1.79% (1/56) | 7.78 | 0.004529 | 0.022551 |
GO:0009678 | hydrogen-translocating pyrophosphatase activity | 1.79% (1/56) | 7.78 | 0.004529 | 0.022551 |
GO:0097525 | spliceosomal snRNP complex | 1.79% (1/56) | 7.78 | 0.004529 | 0.022551 |
GO:0030532 | small nuclear ribonucleoprotein complex | 1.79% (1/56) | 7.78 | 0.004529 | 0.022551 |
GO:0071704 | organic substance metabolic process | 17.86% (10/56) | 1.4 | 0.003994 | 0.02273 |
GO:1901564 | organonitrogen compound metabolic process | 12.5% (7/56) | 1.74 | 0.004681 | 0.022833 |
GO:0019538 | protein metabolic process | 10.71% (6/56) | 1.91 | 0.005011 | 0.023953 |
GO:0009987 | cellular process | 19.64% (11/56) | 1.29 | 0.004523 | 0.024566 |
GO:0005488 | binding | 26.79% (15/56) | 1.04 | 0.0045 | 0.025014 |
GO:0004664 | prephenate dehydratase activity | 1.79% (1/56) | 7.2 | 0.006786 | 0.025743 |
GO:0071826 | ribonucleoprotein complex subunit organization | 1.79% (1/56) | 7.2 | 0.006786 | 0.025743 |
GO:1902679 | negative regulation of RNA biosynthetic process | 1.79% (1/56) | 7.2 | 0.006786 | 0.025743 |
GO:0070461 | SAGA-type complex | 1.79% (1/56) | 7.2 | 0.006786 | 0.025743 |
GO:0022618 | ribonucleoprotein complex assembly | 1.79% (1/56) | 7.2 | 0.006786 | 0.025743 |
GO:0005681 | spliceosomal complex | 1.79% (1/56) | 7.2 | 0.006786 | 0.025743 |
GO:0009094 | L-phenylalanine biosynthetic process | 1.79% (1/56) | 7.2 | 0.006786 | 0.025743 |
GO:0045892 | negative regulation of transcription, DNA-templated | 1.79% (1/56) | 7.2 | 0.006786 | 0.025743 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 1.79% (1/56) | 7.2 | 0.006786 | 0.025743 |
GO:1902223 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid biosynthetic process | 1.79% (1/56) | 7.2 | 0.006786 | 0.025743 |
GO:0051253 | negative regulation of RNA metabolic process | 1.79% (1/56) | 7.2 | 0.006786 | 0.025743 |
GO:0006807 | nitrogen compound metabolic process | 16.07% (9/56) | 1.43 | 0.00564 | 0.026432 |
GO:0006558 | L-phenylalanine metabolic process | 1.79% (1/56) | 6.78 | 0.009038 | 0.028053 |
GO:1902493 | acetyltransferase complex | 1.79% (1/56) | 6.78 | 0.009038 | 0.028053 |
GO:1902221 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process | 1.79% (1/56) | 6.78 | 0.009038 | 0.028053 |
GO:0015269 | calcium-activated potassium channel activity | 1.79% (1/56) | 6.78 | 0.009038 | 0.028053 |
GO:0031248 | protein acetyltransferase complex | 1.79% (1/56) | 6.78 | 0.009038 | 0.028053 |
GO:0016286 | small conductance calcium-activated potassium channel activity | 1.79% (1/56) | 6.78 | 0.009038 | 0.028053 |
GO:0005267 | potassium channel activity | 1.79% (1/56) | 6.78 | 0.009038 | 0.028053 |
GO:0000123 | histone acetyltransferase complex | 1.79% (1/56) | 6.78 | 0.009038 | 0.028053 |
GO:0003729 | mRNA binding | 1.79% (1/56) | 6.78 | 0.009038 | 0.028053 |
GO:0005227 | calcium activated cation channel activity | 1.79% (1/56) | 6.78 | 0.009038 | 0.028053 |
GO:0009095 | aromatic amino acid family biosynthetic process, prephenate pathway | 1.79% (1/56) | 6.78 | 0.009038 | 0.028053 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 1.79% (1/56) | 6.78 | 0.009038 | 0.028053 |
GO:0004427 | inorganic diphosphatase activity | 1.79% (1/56) | 6.78 | 0.009038 | 0.028053 |
GO:0008152 | metabolic process | 19.64% (11/56) | 1.22 | 0.006253 | 0.02874 |
GO:0044260 | cellular macromolecule metabolic process | 10.71% (6/56) | 1.71 | 0.009674 | 0.029642 |
GO:0003824 | catalytic activity | 21.43% (12/56) | 1.09 | 0.008686 | 0.032438 |
GO:0005261 | cation channel activity | 1.79% (1/56) | 6.46 | 0.011285 | 0.032495 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 1.79% (1/56) | 6.46 | 0.011285 | 0.032495 |
GO:0009890 | negative regulation of biosynthetic process | 1.79% (1/56) | 6.46 | 0.011285 | 0.032495 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 1.79% (1/56) | 6.46 | 0.011285 | 0.032495 |
GO:0031327 | negative regulation of cellular biosynthetic process | 1.79% (1/56) | 6.46 | 0.011285 | 0.032495 |
GO:0016853 | isomerase activity | 3.57% (2/56) | 3.56 | 0.0126 | 0.035851 |
GO:0015079 | potassium ion transmembrane transporter activity | 1.79% (1/56) | 6.2 | 0.013527 | 0.035921 |
GO:0000398 | mRNA splicing, via spliceosome | 1.79% (1/56) | 6.2 | 0.013527 | 0.035921 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1.79% (1/56) | 6.2 | 0.013527 | 0.035921 |
GO:0000375 | RNA splicing, via transesterification reactions | 1.79% (1/56) | 6.2 | 0.013527 | 0.035921 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 1.79% (1/56) | 6.2 | 0.013527 | 0.035921 |
GO:0016787 | hydrolase activity | 10.71% (6/56) | 1.6 | 0.014 | 0.036768 |
GO:0070011 | peptidase activity, acting on L-amino acid peptides | 5.36% (3/56) | 2.61 | 0.013169 | 0.037029 |
GO:0006508 | proteolysis | 5.36% (3/56) | 2.56 | 0.014503 | 0.037676 |
GO:0008233 | peptidase activity | 5.36% (3/56) | 2.52 | 0.015374 | 0.039509 |
GO:0031324 | negative regulation of cellular metabolic process | 1.79% (1/56) | 5.98 | 0.015763 | 0.04008 |
GO:0043170 | macromolecule metabolic process | 12.5% (7/56) | 1.39 | 0.01644 | 0.040928 |
GO:0044446 | intracellular organelle part | 5.36% (3/56) | 2.49 | 0.016274 | 0.040942 |
GO:0044422 | organelle part | 5.36% (3/56) | 2.47 | 0.017015 | 0.041923 |
GO:0008408 | 3'-5' exonuclease activity | 1.79% (1/56) | 5.78 | 0.017996 | 0.043444 |
GO:0010629 | negative regulation of gene expression | 1.79% (1/56) | 5.78 | 0.017996 | 0.043444 |